CD38‐negative relapse in multiple myeloma after daratumumab‐based chemotherapy
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Haematology"
DOI: 10.1111/ejh.12902
Abstract: We present a case report of a patient relapsing after anti‐CD38 treatment (daratumumab). The phenotype of the disease changed during this treatment, and the myeloma clone became CD38 negative and daratumumab refractory. We expected clonal… read more here.
Keywords: cd38 negative; myeloma; treatment; cd38 ... See more keywords